Guggenheim upgrades Bristol Myers Squibb to buy, citing promising drug pipeline and potential 21% upside
https://seekingalpha.com/news/4531147-bristol-myers-squibb-upgraded-guggenheim-2026-pipeline-catalysts
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.